Rhythm Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

리듬 파머슈티컬스NASDAQ:RYTM · Nasdaq · Healthcare

$92.83-0.62%

2026-10-02 close

Rhythm Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $130M. 2024 operating profit was −$266M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy